• Portfolio
  • Latest Articles

ONCOLOGY

February 18th

New Portfolio Addition: Arovella Therapeutics

ImpediMed receives order for 16 SOZO units to address lymphoedema

April 1st 2020

ImpediMed receives order for 16 SOZO units to address lymphoedema

Immuron’s shares rise on the back of  Travelan® results

June 12th 2019

Immuron’s shares rise on the back of Travelan® results

Genetic Technologies teams up with TGen

April 8th 2019

Genetic Technologies teams up with TGen

Imugene gains guidance for KEY-Vaxx Immunotherapy development

March 21st 2019

Imugene gains guidance for KEY-Vaxx Immunotherapy development

Imugene onboards renowned cancer scientist Michael Caligiuri

January 7th 2019

Imugene onboards renowned cancer scientist Michael Caligiuri

Connect with us

EXPLORE

  • Finfeed Portfolio
  • Latest Articles
  • How It Works
  • Archived Articles
  • About StocksDigital
  • News
  • PORTFOLIOS

  • Next Investors
  • Catalyst Hunter
  • Wise-Owl
  • STOCKS

    FOLLOW OUR INVESTMENT COMMENTARY & ANALYSIS
      CUSTOMER NOTICE | PRIVACY POLICY | FINANCIAL SERVICES GUIDE | DISCLOSURE POLICY  
    The information in this website is general information only. Any advice is general advice only. Your personal objectives, financial situation or needs have not been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice. S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877).
    © 2021   |   AFSL (CAR No.433913)